Georgios Pongas

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

Amrita Goyal, Daniel E. O’Leary, Kavita Goyal et al. · Journal of the American Academy of Dermatology · 2019 · 50 citations · Full text

Second Primary Hematologic, Immunodeficiencies, Hematology +6

Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study

S. P. Georgiadou, Georgios Pongas, Natalie Fitzgerald et al. · Journal of the Pediatric Infectious Diseases Society · 2012 · 38 citations · Full text

PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma

Georgios Pongas, Christina M. Annunziata, Louis M. Staudt · Oncotarget · 2017 · 31 citations · Full text

Feedback Activation, Immunology, Pathology +17

Activity of Deferasirox in <i>Mucorales</i> : Influences of Species and Exogenous Iron

Russell E. Lewis, Georgios Pongas, Nathaniel D. Albert et al. · Antimicrobial Agents and Chemotherapy · 2010 · 28 citations · Full text